Epidemiological features of cutaneous leishmaniasis in North Khorasan Province in Iran: A cross-sectional study

Abstract

Objective:To investigate the trend and epidemiological status of cutaneous leishmaniasis in the North of Khorasan province, Iran from 2014 to 2022.
Methods:This a cross-sectional study collected and analyzed the information of 849 patients with cutaneous leishmaniasis (CL) through the health center portal from 2014 to 2022. The relationship between sex, number of lesions, and lesion shape was investigated.
Results:Totally 849 participants were included and their mean age was 23.0 ± 20.2 years. The most common parasite species found was Leishmania major (n=714, 84.1%). The number of CL in Esfarayen County increased from 2014 (n=83) to 2022 (n=147) and was more prevalent in men than in women. Furthermore, there was no significant difference in the number and shape of lesions between men and women.
Conclusions:As leishmania major is the predominant type in Esfarayen County of Iran and the number of cases is increasing, it is important to control the reservoir and disease vector in this area. Therefore, a more comprehensive surveillance is suggested.

Keywords

Cutaneous leishmaniasis / Epidemiology / Prevalence / Zoonotic disease / Iran

Conflict of interest statement

The authors claim there is no conflict of interest.

Funding

This study receives no extramural funding.

Data availability statement

The data supporting the findings of this study are available from the corresponding author upon request.

Authors’ contributions

Lakzaei M contributed to interpreting the findings and drafting the manuscript. Jafari F provided guidance in conducting the study, analyzed the data, and wrote the manuscript. Pasokh Z contributed to interpreting the findings and wrote the manuscript. Mohammadi Abnavi M analyzed the data, and wrote the manuscript. Keshvari S compiled and prepared the final data for analysis reviewed the analysis, and wrote the manuscript. Karami H provided guidance in conducting the study, conceptualized the study plan, and edited the manuscript. All authors read and approved the final manuscript for publication.

References

[1] Kaufer A, Ellis J, Stark D, Barratt J. The evolution of trypanosomatid taxonomy. Parasit Vectors 2017; 10(1):287.

[2] Blum JA, Hatz CF. Treatment of cutaneous leishmaniasis in travelers 2009. J Travel Med 2009; 16(2):123-131.

[3] Salah AB, Kamarianakis Y, Chlif S, Alaya NB, Prastacos P. Zoonotic cutaneous leishmaniasis in central Tunisia: Spatio-temporal dynamics. Int J Epidemiol 2007; 36(5):991-1000.

[4] Postigo JAR. Leishmaniasis in the World Health Organization Eastern Mediterranean Region. Int J Antimicrob Agents 2010;36:S62-S65.

[5] Torres-Guerrero E, Quintanilla-Cedillo MR, Ruiz-Esmenjaud J, Arenas R. Leishmaniasis: A review. F1000Res 2017;6:750.

[6] Razavi MR, Shirzadi MR, Mohebali M, et al. Human cutaneous leishmaniosis in Iran, up to date-2019. J Arthropod Borne Dis 2021; 15(2):143-151.

[7] Karami M, Doudi M, Setorki M. Assessing epidemiology of cutaneous leishmaniasis in Isfahan, Iran. J Vector Borne Dis 2013; 50(1):30-37.

[8] Sanei-Dehkordi A, Soleimani-Ahmadi M, Zare M, Mirzaei H. Epidemiological features of cutaneous leishmaniasis and distribution of sand flies in an endemic area in southeast of Iran. Parasite Epidemiol Control 2021;14:e00220.

[9] Kassiri H, Sharifinia N, Jalilian M, Shemshad K. Epidemiological aspects of cutaneous leishmaniasis in Ilam province, west of Iran (2000-2007). Asian Pac J Trop Dis 2012;2:S382-S386.

[10] Bozorg-Omid F, Kafash A, Jafari R, et al. Predicting current and future high-risk areas for vectors and reservoirs of cutaneous leishmaniasis in Iran. Sci Rep 2023; 13(1):11546.

[11] Shirzadi MR, Esfahania SB, Mohebalia M, et al. Epidemiological status of leishmaniasis in the Islamic Republic of Iran, 1983-2012. East Mediterr Health J 2015; 21(10):736-742.

[12] Burza S, Croft SL, Boelaert M. Leishmaniasis. Lancet 2018; 392(10151):951-970.

[13] Sabzevari S, Teshnizi SH, Shokri A, Bahrami F, Kouhestani F. Cutaneous leishmaniasis in Iran: A systematic review and meta-analysis. Microb Pathog 2021;152:104721.

[14] Norouzinezhad F, Ghaffari F, Norouzinejad A, Kaveh F, Gouya MM. Cutaneous leishmaniasis in Iran: Results from an epidemiological study in urban and rural provinces. Asian Pac J Trop Biomed 2016; 6(7):614-619.

[15] Cloots K, Burza S, Malaviya P, et al. Male predominance in reported Visceral Leishmaniasis cases: Nature or nurture? A comparison of population-based with health facility-reported data. PLoS Negl Trop Dis 2020; 14(1):e0007995.

[16] Guerra-Silveira F, Abad-Franch F. Sex bias in infectious disease epidemiology: patterns and processes. PLoS One 2013; 8(4):e62390.

[17] Uribe-Restrepo A, Cossio A, Desai MM, Davalos D, Castro MdM. Interventions to treat cutaneous leishmaniasis in children: A systematic review. PLoS Negl Trop Dis 2018; 12(12):e0006986.

[18] Khosravi A, Sharifi I, Fekri A, et al. Clinical features of anthroponotic cutaneous leishmaniasis in a major focus, Southeastern Iran, 1994-2014. Iran J Parasitol 2017; 12(4):544-553.

[19] Firouraghi N, Bergquist R, Fatima M, et al. High-risk spatiotemporal patterns of cutaneous leishmaniasis: A nationwide study in Iran from 2011 to 2020. Infect Dis Poverty 2023; 12(1):49.

[20] Bamorovat M, Sharifi I, Aflatoonian MR, et al. Risk factors for anthroponotic cutaneous leishmaniasis in unresponsive and responsive patients in a major focus, southeast of Iran. PloS One 2018; 13(2):e0192236.